Buscar
Mostrando ítems 1-10 de 312
Gastric Damage and Cancer-Associated Biomarkers in Helicobacter pylori-Infected Children
(Frontiers Media, 2020)
Helicobacter pylori (H. pylori) is well-known to be involved in gastric carcinogenesis, associated with deregulation of cell proliferation and epigenetic changes in cancer-related genes. H. pylori infection is largely ...
Biomarkers in gingival crevicular fluid: Review of literature
(Universidad Costa Rica, Facultad odontología, 2017)
Biomarkers are molecules that can be objectively measured and evaluated as indicators of normal biological processes, pathological processes or pharmacological responses to therapeutic intervention. In the crevicular ...
Biomarcadores en enfermedad inflamatoria intestinal: ¿sabe cómo utilizarlos?
(Sociedad Médica de Santiago, 2020)
Biomarkers in inflammatory bowel disease are an essential tool in clinical practice. They allow a non-invasive evaluation of patients and thus guide decision-making at different stages of the disease, including diagnostic ...
The Current state of MicroRNAs as restenosis biomarkers
(Frontiers Media, 2020)
In-stent restenosis corresponds to the diameter reduction of coronary vessels following percutaneous coronary intervention (PCI), an invasive procedure in which a stent is deployed into the coronary arteries, producing ...
Systematic review: microRNAs as potential biomarkers in mild cognitive impairment diagnosis
(Frontiers Media, 2022)
The rate of progression from Mild Cognitive Impairment (MCI) to Alzheimer's disease (AD) is estimated at > 10% per year, reaching up to 80-90% after 6 years. MCI is considered an indicator of early-stage AD. In this context, ...
Emerging Noninvasive Biomarkers for Early Detection of Alzheimer's Disease
(2012)
Alzheimer's disease (AD) diagnosis still depends on the triad of clinical, imaging and neuropsychological testing. The development of accurate, easy to use and inexpensive biological markers for AD is a long-standing ...
Autonomic nervous system assessment by pupillary response as a potential biomarker for cardiovascular risk: A pilot study
(Churchill Livingstone, 2019)
Background: Cardiovascular risk (CVR) biomarkers are of increasing interest because of their potential utility in management of cardiovascular diseases. The activity of the autonomic nervous system (ANS) is known to be ...
The Alz-tau Biomarker for Alzheimer's Disease: Study in a Caucasian Population
(IOS Press, 2019)
The establishment of a molecular biomarker for early detection of Alzheimer's disease (AD) is critical for diagnosis and follow up of patients, and as a quantitative parameter in the evaluation of potential new drugs to ...
Plasma Tau Variants Detected by a Novel Anti-Tau Monoclonal Antibody: A Potential Biomarker for Alzheimer’s Disease
(IOP Publishing, 2020)
Background: A major drawback in Alzheimer's disease (AD) is the lack of validated biomarkers for routine clinical diagnostic. We have reported earlier a novel blood biomarker, named Alz-tau (R), based on variants of platelet ...
How we can improve the predictive value of prognostic biomarkers in rheumatoid arthritis
(Future Medicine Ltd., 2015)